Macular Degeneration Association

Therapeutic Areas: Oncology | Hematology

Hematologic Neoplasms Clinical Trials

A listing of Hematologic Neoplasms medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Scottsdale Arizona 85258

A Phase 1 clinical study for patients with Hematologic Neoplasms

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

California

UPDATED

Los Angeles California 90027

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

UPDATED

Palo Alto California 94304

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

UPDATED

San Francisco California 94143

A Phase 1 clinical study for patients with Hematologic Neoplasms

District of Columbia

UPDATED

Washington District of Columbia 20010

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Florida

Gainesville Florida 32610-0277

A clinical trial to evaluate treatments using CC-486 for patients with Hematologic Neoplasm or Neoplasms

Georgia

UPDATED

Atlanta Georgia 30322

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Indiana

Community Clinical Research Center
Anderson Indiana 46011

Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 6 - BGJ398 for Patients With Tumors With FGFR Genetic Alterations

Iowa

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Kansas

Westwood Kansas 66205

A clinical trial seeking patients for a research study for the treatment of Hematologic Neoplasms

Maryland

Baltimore Maryland 21231

A clinical trial to evaluate treatments using CC-486 for patients with Hematologic Neoplasm or Neoplasms

UPDATED

Baltimore Maryland 21287

A Phase 1 clinical study for patients with Hematologic Neoplasms

Massachusetts

UPDATED

Boston Massachusetts 02215

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

UPDATED

Boston Massachusetts 02215

A Phase 1 clinical study for patients with Hematologic Neoplasms

Michigan

UPDATED

Detroit Michigan 48201

A Phase 1 clinical study for patients with Hematologic Neoplasms

Missouri

UPDATED

St. Louis Missouri 63110

A Phase 1 clinical study for patients with Hematologic Neoplasms

New Jersey

New Brunswick New Jersey 08903

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

New York

UPDATED

Bronx New York 10467

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Buffalo New York 14263

A clinical trial seeking patients for a research study for the treatment of Hematologic Neoplasms

UPDATED

New York New York 10032

A clinical research study of BAY1251152 for the treatment of Hematologic Neoplasms

New York New York 10065

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

New York New York 10029

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

New York New York 10021

A Phase 1 clinical study for patients with Hematologic Neoplasms

Oregon

UPDATED

Portland Oregon 97239

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

UPDATED

Portland Oregon 97239

A Phase 1 clinical study for patients with Hematologic Neoplasms

South Carolina

Greenville South Carolina 29605

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Tennessee

UPDATED

Nashville Tennessee 37232

A clinical research study of BAY1251152 for the treatment of Hematologic Neoplasms

Nashville Tennessee 37232-6307

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Texas

Dallas Texas 75390

A clinical trial seeking patients for a research study for the treatment of Hematologic Neoplasms

UPDATED

Dallas Texas 75390

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

UPDATED

Houston Texas 77030

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Houston Texas 77030

A clinical trial to evaluate treatments using CC-486 for patients with Hematologic Neoplasm or Neoplasms

UPDATED

Houston Texas 77030

A Phase 1 clinical study for patients with Hematologic Neoplasms

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

UPDATED

San Antonio Texas 78229

A Phase 1 clinical study for patients with Hematologic Neoplasms

Washington

UPDATED

Seattle Washington 98109

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

UPDATED

Seattle Washington 98109

A Phase 1 clinical study for patients with Hematologic Neoplasms

Australia

Bedford Park 5042

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Darlinghurst 2010

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Woolloongabba 4102

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

China

Beijign

A clinical trial seeking patients for a research study for the treatment of Hematologic Neoplasms

Changchun

A clinical trial seeking patients for a research study for the treatment of Hematologic Neoplasms

Tianjin

A clinical trial seeking patients for a research study for the treatment of Hematologic Neoplasms

France

Paris 75014

A clinical research study of Vemurafenib for the treatment of Solid Tumors, Hematologic Cancers or Metastatic Cancers

Villejuif Ile de France 94805

A clinical research study of Crizotinib for the treatment of Hematologic Cancers, Solid Tumors or Metastatic Cancer

Israel

Haifa 31096

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Jeursalem 91120

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Ramat Gan 57261

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies